137 related articles for article (PubMed ID: 36087560)
1. Brain-age is associated with progression to dementia in memory clinic patients.
Biondo F; Jewell A; Pritchard M; Aarsland D; Steves CJ; Mueller C; Cole JH
Neuroimage Clin; 2022; 36():103175. PubMed ID: 36087560
[TBL] [Abstract][Full Text] [Related]
2. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
[TBL] [Abstract][Full Text] [Related]
3. Interpreting Biomarker Results in Individual Patients With Mild Cognitive Impairment in the Alzheimer's Biomarkers in Daily Practice (ABIDE) Project.
van Maurik IS; Zwan MD; Tijms BM; Bouwman FH; Teunissen CE; Scheltens P; Wattjes MP; Barkhof F; Berkhof J; van der Flier WM;
JAMA Neurol; 2017 Dec; 74(12):1481-1491. PubMed ID: 29049480
[TBL] [Abstract][Full Text] [Related]
4. Cognitive and neuroimaging features and brain β-amyloidosis in individuals at risk of Alzheimer's disease (INSIGHT-preAD): a longitudinal observational study.
Dubois B; Epelbaum S; Nyasse F; Bakardjian H; Gagliardi G; Uspenskaya O; Houot M; Lista S; Cacciamani F; Potier MC; Bertrand A; Lamari F; Benali H; Mangin JF; Colliot O; Genthon R; Habert MO; Hampel H;
Lancet Neurol; 2018 Apr; 17(4):335-346. PubMed ID: 29500152
[TBL] [Abstract][Full Text] [Related]
5. Combined Biomarker Prognosis of Mild Cognitive Impairment: An 11-Year Follow-Up Study in the Alzheimer's Disease Neuroimaging Initiative.
Spencer BE; Jennings RG; Brewer JB;
J Alzheimers Dis; 2019; 68(4):1549-1559. PubMed ID: 30958366
[TBL] [Abstract][Full Text] [Related]
6. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients.
Sluimer JD; van der Flier WM; Karas GB; Fox NC; Scheltens P; Barkhof F; Vrenken H
Radiology; 2008 Aug; 248(2):590-8. PubMed ID: 18574133
[TBL] [Abstract][Full Text] [Related]
7. Cross-sectional and longitudinal characterization of SCD patients recruited from the community versus from a memory clinic: subjective cognitive decline, psychoaffective factors, cognitive performances, and atrophy progression over time.
Kuhn E; Moulinet I; Perrotin A; La Joie R; Landeau B; Tomadesso C; Bejanin A; Sherif S; De La Sayette V; Desgranges B; Vivien D; Poisnel G; Chételat G
Alzheimers Res Ther; 2019 Jul; 11(1):61. PubMed ID: 31286994
[TBL] [Abstract][Full Text] [Related]
8. Dynamics of brain structure and cognitive function in the Alzheimer's disease neuroimaging initiative.
Song X; Mitnitski A; Zhang N; Chen W; Rockwood K;
J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):71-8. PubMed ID: 23123510
[TBL] [Abstract][Full Text] [Related]
9. Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study.
Millar PR; Gordon BA; Luckett PH; Benzinger TLS; Cruchaga C; Fagan AM; Hassenstab JJ; Perrin RJ; Schindler SE; Allegri RF; Day GS; Farlow MR; Mori H; Nübling G; ; Bateman RJ; Morris JC; Ances BM
Elife; 2023 Jan; 12():. PubMed ID: 36607335
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
11. Relationship between cerebral atrophy and number of present teeth in elderly individuals with cognitive decline.
Egashira R; Umezaki Y; Mizutani S; Obata T; Yamaguchi M; Tamai K; Yoshida M; Makino M; Naito T
Exp Gerontol; 2021 Feb; 144():111189. PubMed ID: 33285222
[TBL] [Abstract][Full Text] [Related]
12. Using machine learning to quantify structural MRI neurodegeneration patterns of Alzheimer's disease into dementia score: Independent validation on 8,834 images from ADNI, AIBL, OASIS, and MIRIAD databases.
Popuri K; Ma D; Wang L; Beg MF
Hum Brain Mapp; 2020 Oct; 41(14):4127-4147. PubMed ID: 32614505
[TBL] [Abstract][Full Text] [Related]
13. Improved multimodal prediction of progression from MCI to Alzheimer's disease combining genetics with quantitative brain MRI and cognitive measures.
Reas ET; Shadrin A; Frei O; Motazedi E; McEvoy L; Bahrami S; van der Meer D; Makowski C; Loughnan R; Wang X; Broce I; Banks SJ; Fominykh V; Cheng W; Holland D; Smeland OB; Seibert T; Selbaek G; Brewer JB; Fan CC; Andreassen OA; Dale AM;
Alzheimers Dement; 2023 Nov; 19(11):5151-5158. PubMed ID: 37132098
[TBL] [Abstract][Full Text] [Related]
14. Life course, genetic, and neuropathological associations with brain age in the 1946 British Birth Cohort: a population-based study.
Wagen AZ; Coath W; Keshavan A; James SN; Parker TD; Lane CA; Buchanan SM; Keuss SE; Storey M; Lu K; Macdougall A; Murray-Smith H; Freiberger T; Cash DM; Malone IB; Barnes J; Sudre CH; Wong A; Pavisic IM; Street R; Crutch SJ; Escott-Price V; Leonenko G; Zetterberg H; Wellington H; Heslegrave A; Barkhof F; Richards M; Fox NC; Cole JH; Schott JM
Lancet Healthy Longev; 2022 Sep; 3(9):e607-e616. PubMed ID: 36102775
[TBL] [Abstract][Full Text] [Related]
15. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
16. Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment.
Ten Kate M; Barkhof F; Visser PJ; Teunissen CE; Scheltens P; van der Flier WM; Tijms BM
Alzheimers Res Ther; 2017 Sep; 9(1):73. PubMed ID: 28899429
[TBL] [Abstract][Full Text] [Related]
17. An MRI brain atrophy and lesion index to assess the progression of structural changes in Alzheimer's disease, mild cognitive impairment, and normal aging: a follow-up study.
Zhang N; Song X; Zhang Y; Chen W; D'Arcy RC; Darvesh S; Fisk JD; Rockwood K;
J Alzheimers Dis; 2011; 26 Suppl 3():359-67. PubMed ID: 21971475
[TBL] [Abstract][Full Text] [Related]
18. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population.
Henneman WJ; Sluimer JD; Cordonnier C; Baak MM; Scheltens P; Barkhof F; van der Flier WM
Stroke; 2009 Feb; 40(2):492-8. PubMed ID: 19109551
[TBL] [Abstract][Full Text] [Related]
19. Association of Brain Magnetic Resonance Imaging Signs With Cognitive Outcomes in Persons With Nonimpaired Cognition and Mild Cognitive Impairment.
Wu A; Sharrett AR; Gottesman RF; Power MC; Mosley TH; Jack CR; Knopman DS; Windham BG; Gross AL; Coresh J
JAMA Netw Open; 2019 May; 2(5):e193359. PubMed ID: 31074810
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
